303 related articles for article (PubMed ID: 24166777)
1. p40 (ΔNp63) is more specific than p63 and cytokeratin 5 in identifying squamous cell carcinoma of bronchopulmonary origin: a review and comparative analysis.
Vogt AP; Cohen C; Siddiqui MT
Diagn Cytopathol; 2014 May; 42(5):453-8. PubMed ID: 24166777
[TBL] [Abstract][Full Text] [Related]
2. Combined double CK5/P63 stain: useful adjunct test for diagnosing pulmonary squamous cell carcinoma.
Fatima N; Cohen C; Lawson D; Siddiqui MT
Diagn Cytopathol; 2012 Nov; 40(11):943-8. PubMed ID: 21472873
[TBL] [Abstract][Full Text] [Related]
3. Double staining: diagnostic utility in non-small cell lung carcinoma in the era of tissue conservation.
Hosny Mohammed K; Ewaz A; Cohen C; Siddiqui MT
J Am Soc Cytopathol; 2017; 6(4):170-175. PubMed ID: 31043270
[TBL] [Abstract][Full Text] [Related]
4. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
[TBL] [Abstract][Full Text] [Related]
5. Utilization of p40 (ΔNp63) with p63 and cytokeratin 5/6 immunohistochemistry in non-small cell lung carcinoma fine-needle aspiration biopsy.
Collins BT; Wang JF; Bernadt CT
Acta Cytol; 2013; 57(6):619-24. PubMed ID: 24107322
[TBL] [Abstract][Full Text] [Related]
6. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
[TBL] [Abstract][Full Text] [Related]
7. p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.
Bishop JA; Teruya-Feldstein J; Westra WH; Pelosi G; Travis WD; Rekhtman N
Mod Pathol; 2012 Mar; 25(3):405-15. PubMed ID: 22056955
[TBL] [Abstract][Full Text] [Related]
8. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
Argon A; Nart D; Veral A
Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
[TBL] [Abstract][Full Text] [Related]
9. Differentiating Small Cell Carcinoma From Squamous Cell Carcinoma in Cytologic Specimens: A Head-to-Head Comparison of p40 and p63 Using Cell Block Immunocytochemistry.
Gailey MP; Bellizzi AM; Jensen CS
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):11-5. PubMed ID: 25906121
[TBL] [Abstract][Full Text] [Related]
10. The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung.
van Zyl A; Schubert PT; Koegelenberg CFN
Cytopathology; 2019 Nov; 30(6):586-591. PubMed ID: 31206846
[TBL] [Abstract][Full Text] [Related]
11. Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer.
Kriegsmann K; Cremer M; Zgorzelski C; Harms A; Muley T; Winter H; Kazdal D; Warth A; Kriegsmann M
Pathology; 2019 Apr; 51(3):240-245. PubMed ID: 30798982
[TBL] [Abstract][Full Text] [Related]
12. Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions.
Pu RT; Pang Y; Michael CW
Diagn Cytopathol; 2008 Jan; 36(1):20-5. PubMed ID: 18064689
[TBL] [Abstract][Full Text] [Related]
13. Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer?
Vincenten JP; Smit EF; Grünberg K; Postmus PE; Snijders PJ; Witte BI; Heideman DA; Thunnissen E
Lung Cancer; 2015 Jul; 89(1):19-26. PubMed ID: 25982011
[TBL] [Abstract][Full Text] [Related]
14. A study of ΔNp63 expression in lung non-small cell carcinomas.
Nonaka D
Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298
[TBL] [Abstract][Full Text] [Related]
15. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
Kim MJ; Shin HC; Shin KC; Ro JY
Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
[TBL] [Abstract][Full Text] [Related]
16. p40 (ΔNp63) and keratin 34βE12 provide greater diagnostic accuracy than p63 in the evaluation of small cell lung carcinoma in small biopsy samples.
Butnor KJ; Burchette JL
Hum Pathol; 2013 Aug; 44(8):1479-86. PubMed ID: 23528865
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.
Rekhtman N; Ang DC; Sima CS; Travis WD; Moreira AL
Mod Pathol; 2011 Oct; 24(10):1348-59. PubMed ID: 21623384
[TBL] [Abstract][Full Text] [Related]
18. ΔNp63 (p40) expression in prostatic adenocarcinoma with diffuse p63 positivity.
Uchida K; Ross H; Lotan T; Pignon JC; Signoretti S; Epstein JI; Illei PB
Hum Pathol; 2015 Mar; 46(3):384-9. PubMed ID: 25548110
[TBL] [Abstract][Full Text] [Related]
19. ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
Pelosi G; Rossi G; Cavazza A; Righi L; Maisonneuve P; Barbareschi M; Graziano P; Pastorino U; Garassino M; de Braud F; Papotti M
Int J Surg Pathol; 2013 Jun; 21(3):229-39. PubMed ID: 23486764
[TBL] [Abstract][Full Text] [Related]
20. Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
Kawai T; Tominaga S; Hiroi S; Kameda K; Ogata S; Nakashima H; Ozeki Y; Nakanishi K
Acta Cytol; 2015; 59(6):457-64. PubMed ID: 26696549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]